Clinical trial endpoints don’t always translate to measures of effectiveness in the real world, but no evidence of disease activity (NEDA) may do a better job. Explore how a pooled analysis of ublituximab trials relates to reported effectiveness in a real-world population.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
IPCE CreditsUp to 0.5 creditsAAPA Category 1 Credit™Up to 0.5 creditsAMA PRA Category 1 Credit™Up to 0.5 creditsNursingUp to 0.5 creditsPharmacyUp to 0.5 credits
MOC types
ABIM — Medical KnowledgeUp to 0.5 points
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Address:
- 1515 W Cypress Creek Rd
Pricing
100% of listed courses are free
56 of 56 courses listed here are free.
Collected from the provider’s public pages
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Board review / self-assessment
- Credit · Up to 0.5 credits
- MOC · Up to 0.5 points
- Commercial Support
-
ReleasedMay 5, 2025
-
Last day to claim creditApr 1, 2027 6 months left
-
Efficient CME, CME Outfitters, LLC Livestream: Treating All of MS: Unifying Strategies to Target Relapse and Progression in a Shifting Clinical Landscape
-
Clinical Care Options, LLC (dba Decera Clinical Education) Future Ready MS Care: Decoding Disease Progression and the Expanding Treatment Armamentarium
-
Medscape, LLC Therapeutic Updates in Alzheimer’s Disease: Key Data From the 2025 Alzheimer’s Disease Clinical Trial Conference
